TrialStem cell research & therapy2014

A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus.

Xuebin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.